Expression of tyrosine hydroxylase (TH) in human tumors: a tissue microarray study evaluating 18,666 tumors from 150 different tumor entities

{"TH":[0,33,42,75,116,130,132,176,218,232],"immunohistochemistry":[1],"(IHC)":[2],"has":[3],"been":[4],"proposed":[5],"as":[6],"a":[7,49,182,229],"sensitive":[8],"and":[9,23,46,60,62,102,118,161,180,209,240],"specific":[10,236],"tool":[11],"for":[12,237,247],"the":[13,30,89],"distinction":[14],"of":[15,32,65,88,110,166,193,196],"pheochromocytomas":[16,138],"or":[17],"paragangliomas":[18,152,162,241],"from":[19,55,203],"epithelial":[20],"neuroendocrine":[21,201],"neoplasms":[22,202],"tumors.":[24],"However,":[25],"little":[26],"is":[27,234,244],"known":[28],"about":[29],"prevalence":[31],"expression":[34,43,117],"in":[35,44,77,85,137],"other":[36],"tumor":[37,47,58,112,121,173],"entities.":[38],"To":[39],"comprehensively":[40],"evaluate":[41],"normal":[45,68],"tissues,":[48],"tissue":[50,69],"microarray":[51],"containing":[52],"18,666":[53],"samples":[54,64],"150":[56,111],"different":[57,67],"types":[59,70,174],"subtypes":[61],"608":[63],"76":[66],"were":[71],"analyzed":[72],"by":[73],"IHC.":[74],"immunostaining":[76,233],"tumors":[78],"was":[79,83,134,220],"always":[80],"cytoplasmic.":[81],"It":[82],"detectable":[84,115],"158":[86],"(1%)":[87],"15,630":[90],"analyzable":[91],"tumors,":[92,217],"including":[93,140,147,156],"23":[94],"(0.1%)":[95],"with":[96,100,105,128,142,149,158],"weak,":[97],"28":[98],"(0.2%)":[99],"moderate,":[101],"107":[103],"(0.7%)":[104],"strong":[106,129,143,150,159,170,230],"positivity":[107,177],"Overall,":[108],"14":[109],"categories":[113,122],"showed":[114,169],"only":[119],"5":[120],"included":[123,185],"at":[124,181],"least":[125],"one":[126],"case":[127],"positivity.":[131],"staining":[133,219],"most":[135],"frequent":[136],"(100%,":[139],"74.0%":[141],"positivity),":[144,151,160],"ganglioneuroma":[145],"(25.0%;":[146],"16.7%":[148],"\\"probably":[153,163],"sympathetic\\"":[154],"(50.0%;":[155],"43.8%":[157],"parasympathetic\\"":[164],"(13.6%;":[165],"which":[167],"all":[168],"positivity).":[171],"Other":[172],"showing":[175],"less":[178],"commonly":[179],"lower":[183],"level":[184],"medullary":[186],"thyroid":[187],"carcinoma":[188],"(5.9%),":[189],"squamous":[190],"cell":[191],"carcinomas":[192],"several":[194,204],"organs":[195,205],"origin":[197],"(up":[198,206],"to":[199,207,223],"4.5%),":[200],"4.3%)":[208],"colorectal":[210],"adenocarcinoma":[211],"(0.2%).":[212],"In":[213,227],"\\"non-neural":[214],"crest\\"":[215],"derived":[216],"often":[221],"limited":[222],"few":[224],"interspersed":[225],"cells.":[226],"conclusion,":[228],"positive":[231],"highly":[235],"pheochromocytomas,":[238],"ganglioneuroma,":[239],"although":[242],"sensitivity":[243],"<":[245],"30%":[246],"paragangliomas.":[248]}